System and method for enhancement of glucose production by stimulation of pancreatic beta cells
AssigneeMedtronic, Inc.
InventorsRichard P. M. Houben, Alexis C. M. Renirie
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedtronic, Inc.
InventorsRichard P. M. Houben, Alexis C. M. Renirie
Estimating the term…
There is provided a system for automatically responding to insulin demand without any need for external monitoring or injecting of insulin into the diabetic patient. The system provides for sensing glucose levels internally, and responding by stimulating either the pancreas or a transplant of pancreatic islets in order to enhance insulin production. The enhancing stimulation is delivered at a rate greater than the burst rate, or is otherwise controlled so that the depolarization burst constitutes a greater portion of each islet electrical cycle, thereby resulting in increased insulin production. The system also provides for continuous glucose monitoring, and reacts to sensed hypoglycemia by delivering stimulus pulses timed to reduce the burst durations, and thus to inhibit insulin production. In another embodiment, the system responds to a good intake signal, either externally or internally generated, by going through a time response algorithm to provide a stimulation-enhanced insulin response which simulates the natural response. In yet another embodiment, the functionality of an islet transplant is continually monitored, and performance data is logged and down loaded on command to an external programmer. The stimulation of patient pancreatic cells may be combined with administration of a hypoglycemic agent.
A system for stimulating pancreatic beta cells located at a predetermined patient location for the purpose of increasing insulin production by such beta cells, comprising:
A system implantable in a patient for detecting and responding to patient hypoglycemia, comprising:
An implantable system for sensing electrical activity of pancreatic beta cells and stimulating said beta cells to promote increased insulin production therefrom, comprising:
A system for delivering a timed insulin response to start of food intake by a patient, comprising:
A system for monitoring functionality of an islet transplant in a patient, comprising:
A method of increasing insulin production by stimulating insulin-producing islets in a patient, comprising:
A method of responding to patient food intake by delivering insulin in accord with a predetermined time response, comprising:
A method of enhancing insulin production in a patient concurrently with the administration of a hypoglycemic agent to the patient, comprising determining when a said agent has been administered to the patient, and initiating a stimulation program following said determining, and stimulating insulin-producing islets in said patient in accord with said program.
A system for enhancing production of insulin by a patient's pancreas, comprising:
A system for delivering a timed insulin response to start of food intake by a patient, comprising:
Dependencies are inferred from the claim text.